Emerg Infect Dis by Griggs, Anne et al.
LETTERS
by desquamation of palms and soles 
(Figure). Laboratory tests detected 
leukopenia and thrombocytopenia. 
Test results for Plasmodium spp. and 
dengue virus were negative, and blood 
culture results were negative as well. 
By using ELISA, anti-CHIKV IgM 
antibodies were detected 10 days after 
onset of symptoms, and anti-CHIKV 
IgG antibodies (titer 25,600) were 
detected 8 months later.
Both patients were diagnosed after 
the viremic period; no virus could be 
isolated or genotyped. Nevertheless, 
health authorities were alerted and 
appropriate control measures were 
taken.
Travelers can serve as sentinels 
for the introduction of viruses into 
previously non–disease-endemic 
areas. Several reports have been 
made of travelers carrying CHIKV 
to and from many regions of the 
world (2,4–6). Recent identifi cation 
of the expansion of infested areas 
by Ae. aegypti and Ae. albopictus 
mosquitoes, population susceptibility 
for the virus, and the constant 
journeying of travelers from affected 
areas are relevant indications of the 
risk for introduction and sustained 
transmission of CHIKV in Brazil.
Health care professionals and 
public health authorities should be 
aware of the epidemiologic and 
clinical aspects of CHIKV infection 
and diagnoses to adopt prompt 
control measures to avoid CHIKV 
transmission in Brazil. Healthcare 
facilities and epidemiologic 
surveillance teams have jointly 
implemented CHIKV prevention 
and control measures. To date, no 
autochthonous transmission of 
CHIKV has been reported in Brazil.
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To the Editor: White-nose 
syndrome (WNS) is an emerging 
fungal disease in bats that was 
fi rst described near Albany, New 
York, USA, in February 2006 (1). 
The causative agent, Geomyces 
destructans, is a psychrophilic (cold-
loving) fungus that infects the skin of 
bats and leads to depletion of their fat 
stores during hibernation (2). WNS has 
caused dramatic cumulative mortality 
rates (up to 99%) in some winter 
hibernacula and has killed millions of 
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bats among 6 cave-roosting species in 
19 central and eastern US states and 
4 Canadian provinces (3). In addition, 
the fungus has been identifi ed in 2 
additional US states, although bat 
deaths have not been associated with 
it. No evidence has been found that 
WNS is transmitted from bats to 
humans, although humans may play 
a role in translocation of the fungus 
between caves (4,5).
Current surveillance for WNS 
is time- and labor-intensive. Wildlife 
personnel typically enter caves, 
inspect hibernacula, and collect bats 
with clinically compatible signs for 
testing (4). In July 2010, the National 
Park Service (NPS) Offi ce of Public 
Health proposed an expanded WNS 
surveillance strategy that involved 
using opportunistic sampling of bats 
already submitted to state public health 
laboratories for rabies testing; the 
bats submitted include species known 
to be susceptible to WNS. The pilot 
study focused on the region around 
Mammoth Cave National Park, the 
world’s longest known cave system and 
home to 13 bat species (2 endangered), 
in south-central Kentucky (6). At the 
time of initial discussions, Kentucky 
was WNS-free, but the bordering state 
of Tennessee had recently reported 
its fi rst WNS cases in spring 2010 
in a cave system located <130 km 
from Mammoth Cave. WNS was fi rst 
detected in Kentucky in April 2011 in 
Trigg County (180 km from Mammoth 
Cave) (7).
The goals of this pilot study 
were to 1) enhance WNS surveillance 
in counties in and near Mammoth 
Cave and 2) demonstrate a feasible, 
cost-effective surveillance system. 
NPS Offi ce of Public Health staff 
coordinated meetings in Kentucky 
and Tennessee with representatives 
from the state departments of wildlife 
and health and other partnering 
organizations. Key representatives 
at one or both of these meetings 
included the state epidemiologist, the 
state public health veterinarian, the 
public health laboratory director, state 
wildlife biologists, and NPS and state 
wildlife veterinarians. Also attending 
both meetings was a veterinary 
pathologist from the Southeastern 
Cooperative Wildlife Disease Study 
(SCWDS) in Athens, Georgia, USA, 
one of 3 laboratories that test most 
samples for WNS in the United States. 
The surveillance concept was well 
received in both states, and state-
specifi c protocols were developed 
for submitting rabies-negative bats 
to SCWDS only during hibernation 
months (November–April) when 
WNS is more likely to be detected 
(8). In Kentucky, a memorandum 
of understanding was drafted that 
outlined roles and responsibilities 
of collaborating agencies. The 
memorandum was reviewed by legal 
advisors and signed by public health 
and wildlife offi cials.
Both protocols outlined key 
elements of the submission process, 
including how laboratory personnel 
were to submit rabies-negative bats 
to SCWDS for WNS testing (fungal 
culture, histopathologic examination, 
and PCR), how bats were to be stored 
or destroyed after testing, and the 
chain of communication for reporting 
test results. Whenever possible, 
bats were frozen at −20°C within 48 
hours following rabies testing, and 
their muzzles and forearms were left 
intact to maximize the yield for G. 
destructans and to facilitate species 
identifi cation. Protocols included 
additional criteria to improve 
testing effi ciency (e.g., prioritizing 
submissions on the basis of known 
WNS-susceptible species or counties 
where cave-roosting colonies are 
located). A project-specifi c version of 
the standard SCWDS submission form 
was completed for all samples. All 
funding and resources were provided 
in kind by respective agencies.
In October 2010, the Tennessee 
State Public Health Laboratory 
submitted 34 rabies-negative bats 
(archived during January–April 2010, 
before pilot study discussions) from 18 
counties to SCWDS; all were WNS-
negative. Twenty-one additional 
rabies-negative bats from 9 Tennessee 
counties collected during November 
2010–April 2011 also tested negative 
for WNS. In Kentucky, 64 rabies-
negative bats (from 22 counties) 
were submitted during November 
2011–January 2012; all were WNS-
negative except 1 bat tested on 
January 13, 2012, which was the 
fi rst known WNS-positive bat from 
Fayette County, a primarily urban area 
in northern central Kentucky where 
little cave-based WNS surveillance 
is conducted. Overall, although 
the sample of bats tested to date is 
modest and likely insuffi cient as a 
stand-alone surveillance system, 
these results supplement other data 
and can inform the development of 
interventions, prevention messages, 
and transmission models.
This pilot study highlights several 
observations and implications. First, 
it demonstrates that opportunistic 
testing of rabies-negative bats for 
WNS can be facilitated between state 
departments of wildlife and health 
through interagency collaboration. 
Second, the surveillance system is low 
cost and could potentially be expanded 
to other states where WNS is likely 
to emerge and where statewide cave-
based surveillance is cost-prohibitive. 
Last, this project showcases a unique 
interdisciplinary collaboration in 
wildlife and human health, disease 
ecology, and environmental steward-
ship. Such partnerships are 
championed by the One Health 
approach (9) and are central to the 
mission of NPS to protect the health of 
all species and our environment (10).
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To the Editor: The novel metallo-
β-lactamase named New Delhi 
metallo-β-lactamase (NDM-1) was 
identifi ed from Klebsiella pneumoniae 
and Escherichia coli isolates in 
Sweden from a patient previously 
hospitalized in India (1). NDM-1 
is spreading rapidly worldwide to 
nonclonally related isolates, many 
of which are directly or indirectly 
tracked to the Indian subcontinent (2). 
A carbapenem-resistant K. pneumoniae 
strain, KLZA, was isolated in May 
2009 from the culture of a blood 
sample from of a 40-year-old man on 
the day after his admission to a surgical 
intensive care unit of the Clinical 
Hospital Center in Zagreb, Croatia. 
The patient had been transferred after 
5 days of hospitalization in Bosnia and 
Herzegovina following a car accident. 
The clinical history mentioned 
antimicrobial drug treatment that did 
not include carbapenems (gentamicin, 
metronidazole, and ceftriaxone) and 
no link to the Indian subcontinent. 
Antimicrobial drug susceptibility 
testing was performed by Vitek2 
(bioMérieux, Marcy-l’Etoile, France) 
and broth microdilution and interpreted 
according to the latest documents 
from the European Committee 
on Antimicrobial Susceptibility 
Testing (www.eucast.org/clinical_
breakpoints/, version 1.1).
The strain proved resistant to 
imipenem and meropenem, to all 
broad-spectrum cephalosporins, and 
to aminoglycosides and susceptible 
to ciprofl oxacin and tigecycline 
(Table). We checked for blaVIM, blaIMP, 
blaSPM, blaGIM, blaSIM, and blaNDM 
resistance genes by using PCR. A 
PCR product was obtained only 
with the NDM primers, after being 
purifi ed (QIAquick PCR Purifi cation 
Kit, QIAGEN, Hilden, Germany), its 
sequence showed 100% identity with 
blaNDM-1.
Strain genotyping was performed 
by multilocus sequence typing to 
determine the sequence type (ST) 
of the isolate and to establish a 
comparison with previously reported 
NDM-1–producing isolates. Allelic 
numbers were obtained on the basis 
of sequences of 7 housekeeping 
genes at www.pasteur.fr/recherche/
genopole/PF8/mlst/Kpneumoniae.
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